Q BioMed SG&A Expense (Quarterly) Trends

Q BioMed Inc (QBIO)

0.0005 0.00 (0.00%) USD | OTCM | May 03, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
February 28, 2023	0.4398M
November 30, 2022	0.4757M
August 31, 2022	0.7201M
May 31, 2022	1.019M
February 28, 2022	1.096M
November 30, 2021	1.235M
August 31, 2021	1.372M
May 31, 2021	1.520M
February 28, 2021	2.137M
November 30, 2020	2.309M
August 31, 2020	1.492M
May 31, 2020	1.598M
February 29, 2020	5.57M
November 30, 2019	1.074M
August 31, 2019	0.9684M
May 31, 2019	1.196M
February 28, 2019	1.243M
November 30, 2018	1.234M
August 31, 2018	1.996M

Date	Value
May 31, 2018	1.231M
February 28, 2018	1.321M
November 30, 2017	3.149M
August 31, 2017	3.038M
May 31, 2017	1.677M
February 28, 2017	1.408M
November 30, 2016	1.394M
August 31, 2016	1.151M
May 31, 2016	0.7058M
February 29, 2016	1.781M
November 30, 2015	0.309M
August 31, 2015	0.0332M
May 31, 2015	0.0038M
February 28, 2015	0.0082M
November 30, 2014	0.0195M
August 31, 2014	0.0061M
May 31, 2014	0.0046M
February 28, 2014	0.0079M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.4398M

Minimum

Feb 2023

5.57M

Maximum

Feb 2020

1.514M

Average

1.215M

Median

SG&A Expense (Quarterly) Benchmarks